Article Listing - KETOROLAC ADVERSE REACTIONS DECLINE

GLOOMY 1st QTR RESULTS AT HOECHST

4 May 1992

The German chemical and pharmaceutical group Hoechst has announced declines in profit for the first quarter of 1992. Pretax profit...

SALES UP 17% AT SANDOZ IN 1st QTR

4 May 1992

Swiss chemical and pharmaceutical concern Sandoz posted a sales increase in the first quarter of 1992 of 17% to 4.1...

HYPOLIPEMIC RESEARCH IN JAPAN

4 May 1992

Scientists at the Institute of Physical and Chemical Res-earch in Saitama, Japan, are investigating the compound 4-cholesten-3-one for its...

LIPOSOME TECHNOLOGY'S MELISSA YEAGER

4 May 1992

Liposome Technology has appointed Melissa Yeager to the position of associate director for regulatory affairs.

RUSSIA PLANS HEALTH INSURANCE

4 May 1992

The republic of Russia is planning to introduce a system of compulsory health insurance for all its 157 million people,...

GOOD 1st QTRs for ALZA, IMMUNEX AND MYLAN

4 May 1992

Alza Corp, Immunex and Mylan Laboratories are the three best performers among the US pharmaceutical companies that have announ-ced quarterly...

RETROVIR TO VIDEX SWITCH BENEFIT

4 May 1992

Switching HIV-infected patients who have received treatment with Wellcome's Retrovir (zidovudine) for over 16 weeks over to Bristol-Myers Squibb's Videx...

FORTHCOMING MEETINGS

4 May 1992

Among the forthcoming meetings and conferences of interest to the industry are:

- International Harmonization: The Outcome of ICH1 and the...

WORLD NEWS IN BRIEF

4 May 1992

- The Minister of Industry of Iraq, Hammoudi Al-Saadi, has requested the International Committee of the Red Cross for help...

"INADEQUACY' OF GATT PATENT REGS

4 May 1992

The present round of negotiations at the General Agreement on Trade and Tariffs, even if they are successful, will bring...